1.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)

Lau, G, Yu, ML, Wong     More...

Lau, G, Yu, ML, Wong, GC, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, JM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tanwandee, T, Sarin, SK, Omata, M     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2022, Volume 16, Issue 2, Pages 486-487

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2023影響因子:  5.9  发表年影響因子:  6.6 

2.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

Lau, G, Yu, ML, Wong     More...

Lau, G, Yu, ML, Wong, G, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, EM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tawesak, T, Sarin, SK, Omata, M     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2021, Volume 15, Issue 5, Pages 1031-1048

收錄情况： WOS SCOPUS

WOS核心合集引用: 77  2023影響因子:  5.9  发表年影響因子:  9.046 

3.Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

Liu, HL, He, X, Wang     More...

Liu, HL, He, X, Wang, YD, Zhou, SN, Zhang, DL, Zhu, JY, He, Q, Zhu, ZJ, Li, GM, Sun, LB, Wang, JL, Cheng, G, Liu, ZW, Lau, G     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 432-436

收錄情况： WOS SCOPUS

WOS核心合集引用: 46  2023影響因子:  5.9  发表年影響因子:  6.047 

4.Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

Lau, G, Sharma, M     More...

Lau, G, Sharma, M     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 415-428

收錄情况： WOS SCOPUS

WOS核心合集引用: 51  2023影響因子:  5.9  发表年影響因子:  6.047 

5.Effect of COVID-19 on patients with compensated chronic liver diseases

Ji, D, Zhang, DW, Ya     More...

Ji, D, Zhang, DW, Yang, TN, Mu, JS, Zhao, P, Xu, J, Li, C, Cheng, G, Wang, YD, Chen, Z, Qin, EQ, Lau, G     Less

HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 5, Pages 701-710

收錄情况： WOS SCOPUS

WOS核心合集引用: 51  2023影響因子:  5.9  发表年影響因子:  6.047